Shandong Xinhua Pharmaceutical Company Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shandong Xinhua Pharmaceutical Company Limited with three other
companies in this sector in China:
Zhejiang NHU Co.,Ltd
sales of 3.82 billion Chinese Renmimbi [US$556.91 million]
of which 95%
was Pharmaceutical Chemicals),
Shandong Lukang Pharmaceutical
(2.41 billion Chinese Renmimbi [US$351.46 million]
of which 71%
was Human Antibiotic), and
Apeloa Pharmaceutical Co Ltd
(4.34 billion Chinese Renmimbi [US$632.71 million]
of which 100%
was Health Care & Pharmaceutical).
During the year ended December of 2015, sales at
Shandong Xinhua Pharmaceutical Company Limited were 3.60 billion Chinese Renmimbi (US$524.67 million).
a very small
increase of 1.8%
versus 2014, when the company's sales were 3.53 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Shandong Xinhua Pharmaceutical Company Limited
(and since 2010, sales have increased a total of 39%).
Sales of Preparations saw an increase
that was more than double the company's growth rate: sales were up
89.1% in 2015, from
876.97 million Chinese Renmimbi to 1.66 billion Chinese Renmimbi.